David de Semir

1.4k total citations
31 papers, 920 citations indexed

About

David de Semir is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David de Semir has authored 31 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in David de Semir's work include RNA Interference and Gene Delivery (8 papers), MicroRNA in disease regulation (6 papers) and Melanoma and MAPK Pathways (5 papers). David de Semir is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), MicroRNA in disease regulation (6 papers) and Melanoma and MAPK Pathways (5 papers). David de Semir collaborates with scholars based in United States, Spain and Germany. David de Semir's co-authors include Mohammed Kashani–Sabet, Mehdi Nosrati, Altaf A. Dar, Vladimir Bezrookove, Shahana Majid, Josep M. Aran, Rosalie Maurisse, Dieter C. Gruenert, Alireza Abdolmohammadi and Hamid Emamekhoo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

David de Semir

30 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David de Semir United States 15 737 345 167 117 82 31 920
David Brocks Germany 10 584 0.8× 266 0.8× 151 0.9× 76 0.6× 94 1.1× 14 807
Bruno Pereira Portugal 13 773 1.0× 376 1.1× 153 0.9× 72 0.6× 68 0.8× 20 1.0k
Arthur Kwok Leung Cheung Hong Kong 18 698 0.9× 362 1.0× 337 2.0× 81 0.7× 94 1.1× 27 1.1k
James C. Lang United States 17 720 1.0× 413 1.2× 455 2.7× 65 0.6× 126 1.5× 27 1.2k
Ruping Sun United States 12 613 0.8× 619 1.8× 257 1.5× 172 1.5× 114 1.4× 20 1.1k
Alexander Polyzos Greece 14 744 1.0× 188 0.5× 157 0.9× 66 0.6× 68 0.8× 25 952
Bijay Dhungel Australia 14 415 0.6× 173 0.5× 233 1.4× 150 1.3× 91 1.1× 22 688
Serena Fernandez Italy 9 916 1.2× 343 1.0× 530 3.2× 84 0.7× 72 0.9× 9 1.1k
Ronglin Xie United States 18 754 1.0× 183 0.5× 264 1.6× 101 0.9× 44 0.5× 31 1.0k
Archontoula Stoffel United States 12 548 0.7× 166 0.5× 259 1.6× 101 0.9× 80 1.0× 15 826

Countries citing papers authored by David de Semir

Since Specialization
Citations

This map shows the geographic impact of David de Semir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David de Semir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David de Semir more than expected).

Fields of papers citing papers by David de Semir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David de Semir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David de Semir. The network helps show where David de Semir may publish in the future.

Co-authorship network of co-authors of David de Semir

This figure shows the co-authorship network connecting the top 25 collaborators of David de Semir. A scholar is included among the top collaborators of David de Semir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David de Semir. David de Semir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Kevin B., Pierre‐Yves Desprez, David de Semir, et al.. (2025). Phase II Study of Niraparib in Patients With Advanced Melanoma With Homologous Recombination Pathway Gene Mutations. JCO Precision Oncology. 9(9). e2400658–e2400658. 1 indexed citations
2.
Semir, David de, Vladimir Bezrookove, Mehdi Nosrati, et al.. (2021). Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation–Induced DNA Damage and Melanoma Susceptibility. Cancer Research. 81(11). 2956–2969. 12 indexed citations
3.
Semir, David de, Vladimir Bezrookove, Mehdi Nosrati, et al.. (2018). PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer. Proceedings of the National Academy of Sciences. 115(25). E5766–E5775. 16 indexed citations
4.
Bezrookove, Vladimir, Mehdi Nosrati, James R. Miller, et al.. (2018). Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma. Clinical Cancer Research. 24(17). 4119–4125. 10 indexed citations
5.
Zhou, Wen, Mehdi Nosrati, Shahana Majid, et al.. (2014). Antitumor Activity of miR-1280 in Melanoma by Regulation of Src. Molecular Therapy. 23(1). 71–78. 21 indexed citations
6.
Dar, Altaf A., Shahana Majid, David de Semir, et al.. (2013). The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression. JNCI Journal of the National Cancer Institute. 105(6). 433–442. 92 indexed citations
7.
Bezrookove, Vladimir, David de Semir, Mehdi Nosrati, et al.. (2013). Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration. Journal of Investigative Dermatology. 134(3). 783–790. 12 indexed citations
8.
Semir, David de, Mehdi Nosrati, Vladimir Bezrookove, et al.. (2012). Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Proceedings of the National Academy of Sciences. 109(18). 7067–7072. 30 indexed citations
9.
Semir, David de, Rosalie Maurisse, Fuliang Du, et al.. (2012). Generation of SV40-transformed rabbit tracheal-epithelial-cell-derived blastocyst by somatic cell nuclear transfer. Cell and Tissue Research. 347(2). 357–367. 2 indexed citations
10.
Dar, Altaf A., Shahana Majid, David de Semir, et al.. (2011). miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein. Journal of Biological Chemistry. 286(19). 16606–16614. 202 indexed citations
11.
Dar, Altaf A., Shahana Majid, Mehdi Nosrati, et al.. (2010). Functional Modulation of IGF-Binding Protein-3 Expression in Melanoma. Journal of Investigative Dermatology. 130(8). 2071–2079. 26 indexed citations
12.
Torabian, Sima, David de Semir, Mehdi Nosrati, et al.. (2009). Ribozyme-Mediated Targeting of IκBγ Inhibits Melanoma Invasion and Metastasis. American Journal Of Pathology. 174(3). 1009–1016. 8 indexed citations
13.
Larriba, Sara, David de Semir, Itziar Martínez-González, et al.. (2008). N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel. Human Mutation. 29(5). 738–749. 23 indexed citations
14.
Semir, David de, Mehdi Nosrati, Shang Li, & Mohammed Kashani–Sabet. (2007). Telomerase: Going Beyond the Ends. Cell Cycle. 6(5). 546–549. 8 indexed citations
15.
16.
Aran, Josep M. & David de Semir. (2004). Response. Oligonucleotides. 14(2). 158–160. 1 indexed citations
17.
Semir, David de, Marga Nadal, Juan R. González, et al.. (2003). Suitability of oligonucleotide‐mediated cystic fibrosis gene repair in airway epithelial cells. The Journal of Gene Medicine. 5(7). 625–639. 5 indexed citations
18.
Semir, David de & Josep M. Aran. (2003). Misleading Gene Conversion Frequencies Due to a PCR Artifact Using Small Fragment Homologous Replacement. Oligonucleotides. 13(4). 261–269. 18 indexed citations
19.
Semir, David de, Jordi Pétriz, Sara Larriba, et al.. (2002). Non‐viral vector‐mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells. The Journal of Gene Medicine. 4(3). 308–322. 14 indexed citations
20.
Semir, David de, Sara Larriba, Virginia Nunes, et al.. (2002). Quantitative assessment of chimeraplast stability in biological fluids by polyacrylamide gel electrophoresis and laser-assisted fluorescence analysis.. Pharmaceutical Research. 19(6). 914–918. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Brocks Breakdown of academic impact, for papers by Bruno Pereira Breakdown of academic impact, for papers by Arthur Kwok Leung Cheung Breakdown of academic impact, for papers by James C. Lang Breakdown of academic impact, for papers by Ruping Sun Breakdown of academic impact, for papers by Alexander Polyzos Breakdown of academic impact, for papers by Bijay Dhungel Breakdown of academic impact, for papers by Serena Fernandez Breakdown of academic impact, for papers by Ronglin Xie Breakdown of academic impact, for papers by Archontoula Stoffel
Rankless by CCL
2026